[144] Integral Ad Science Holding Corp. SEC Filing

Rhea-AI Filing Summary

Disc Medicine, Inc. (NASDAQ: IRON) – Form 144 filing overview

An insider—identified in the filing’s prior-sales table as Jean Franchi—has notified the SEC of an intention to sell 2,000 common shares of Disc Medicine. The shares will be routed through Morgan Stanley Smith Barney LLC on or about 10 July 2025. Based on the filing’s quoted price, the aggregate market value of the proposed sale is $111,720. The company has 34,634,000 shares outstanding; the proposed disposition therefore represents roughly 0.006 % of shares outstanding.

Acquisition background: The shares derive from restricted stock units (RSUs) granted on 15 Feb 2025. No cash payment was required when the RSUs were awarded.

Recent trading history: The same account executed a Rule 10b5-1 sale of 2,000 shares on 16 Jun 2025 for $104,518.80 in gross proceeds.

Key take-aways for investors:

• The filing is a routine Form 144 notice; it does not itself execute a sale but provides advance disclosure.
• The dollar amount is modest relative to Disc Medicine’s market capitalization and float, indicating limited direct market impact.
• Successive 2,000-share sales within a month may nevertheless be monitored as an insider-selling trend, especially if additional filings appear.

Insights

Securities Analyst

TL;DR: Insider files to sell 2,000 IRON shares (~$112k); negligible size but follow insider-selling trend.

The Form 144 signals that insider Jean Franchi plans to dispose of 2,000 Disc Medicine shares—about six-thousandths of outstanding stock. A prior 2,000-share sale in June suggests a structured selling program, likely under a 10b5-1 plan. Given the tiny percentage and transparent advance notice, the filing is immaterial to valuation. However, consecutive sales can influence sentiment in thinly traded biotech names, so investors may wish to track future filings for escalation. No operational or financial data are included.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8285	68666.08	165016300	07/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/03/2025	Restricted Stock Vesting	Issuer			8285	07/03/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lisa Utzschneider 12 E 49th Street 20th Floor New York NY 10017	Common	05/07/2025	8367	61701.60
Lisa Utzschneider 12 E 49th Street 20th Floor New York NY 10017	Common	07/08/2025	14904	123850.75

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Disc Medicine (IRON) disclose in the latest Form 144?

A notice that insider Jean Franchi plans to sell 2,000 common shares valued at $111,720 around 10 Jul 2025.

How large is the proposed insider sale relative to shares outstanding?

The 2,000 shares equal roughly 0.006 % of Disc Medicine’s 34.6 million shares outstanding.

Were there recent insider sales prior to this filing?

Yes. The same account sold 2,000 shares on 16 Jun 2025 for $104,518.80 in gross proceeds.

Is the Form 144 filing itself a sale?

No. Form 144 is a pre-sale notice; the actual transaction may occur on or after the listed approximate date.

Which broker will execute the sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.

What was the source of the shares to be sold?

They originated from restricted stock units granted on 15 Feb 2025.